Shopping Cart 0
Cart Subtotal
USD 0

DxTerity Diagnostics Inc-Product Pipeline Analysis, 2017 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

DxTerity Diagnostics Inc (DxTerity) is a medical device company that offers molecular diagnostic solutions. The company develops genomic tests for disease diagnosis and monitoring in its genomics laboratory. The company's patient clinical research platform and dxcollect fingerstick collection kit are used for population scale genomic studies. DxTerity's dxdirect technology facilitates the direct blood testing of RNA and DNA. The company's blood based genomic tests include radiation exposure dosage index test; radiation toxicity test and rheumatoid arthritis test. It also offers a range of analytic services including curation of bioinformatics databases and analysis of RNA and DNA sequence data. DxTerity is headquartered in Rancho Dominguez, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company DxTerity Diagnostics Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

DxTerity Diagnostics Inc Company Overview 4

DxTerity Diagnostics Inc Company Snapshot 4

DxTerity Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

DxTerity Diagnostics Inc-Pipeline Analysis Overview 7

DxTerity Diagnostics Inc-Key Facts 7

DxTerity Diagnostics Inc-Major Products and Services 8

DxTerity Diagnostics Inc Pipeline Products by Development Stage 9

DxTerity Diagnostics Inc Pipeline Products Overview 11

DxCollect Blood Collection Tubes 11

DxCollect Blood Collection Tubes Product Overview 11

RadTox Test 12

RadTox Test Product Overview 12

RADx 13

RADx Product Overview 13

REDI-Dx 14

REDI-Dx Product Overview 14

REDI-Dx High Throughput Radiation Biodosimetry Test 15

REDI-Dx High Throughput Radiation Biodosimetry Test Product Overview 15

DxTerity Diagnostics Inc-Key Competitors 16

DxTerity Diagnostics Inc-Key Employees 17

DxTerity Diagnostics Inc-Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

DxTerity Diagnostics Inc, Recent Developments 19

Oct 04, 2016: DxTerity Diagnostics Awarded Up to $150 Million BARDA Contract for Advanced Development and Delivery of REDI-Dx High Throughput Radiation Biodosimetry Test 19

Dec 20, 2013: DxTerity's REDI-Dx Wins 2013 NCT CBRNe Product of the Year Award 19

Appendix 21

Methodology 21

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

DxTerity Diagnostics Inc Pipeline Products by Equipment Type 5

DxTerity Diagnostics Inc Pipeline Products by Development Stage 9


List Of Table

List of Tables

DxTerity Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

DxTerity Diagnostics Inc Pipeline Products by Equipment Type 5

DxTerity Diagnostics Inc Pipeline Products by Indication 6

DxTerity Diagnostics Inc, Key Facts 7

DxTerity Diagnostics Inc, Major Products and Services 8

DxTerity Diagnostics Inc Number of Pipeline Products by Development Stage 9

DxTerity Diagnostics Inc Pipeline Products Summary by Development Stage 10

DxCollect Blood Collection Tubes-Product Status 11

DxCollect Blood Collection Tubes-Product Description 11

RadTox Test-Product Status 12

RadTox Test-Product Description 12

RADx-Product Status 13

RADx-Product Description 13

REDI-Dx-Product Status 14

REDI-Dx-Product Description 14

REDI-Dx High Throughput Radiation Biodosimetry Test-Product Status 15

REDI-Dx High Throughput Radiation Biodosimetry Test-Product Description 15

DxTerity Diagnostics Inc, Key Employees 17

Glossary 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Pathway Genomics Corp, MedGenome Inc, Cynvenio Biosystems Inc